Medical Imaging Corporation (TPEX:6637)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
60.90
-0.10 (-0.16%)
Aug 19, 2026, 10:41 AM CST

Medical Imaging Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
147.49185.54165.02121.34111.676.78
Depreciation & Amortization
56.3552.9452.6444.4252.7856.24
Loss (Gain) From Sale of Assets
-2.09-5.02-8.33-0.75-1.24-1.65
Loss (Gain) From Sale of Investments
7.512.881.9943.0610.126.25
Loss (Gain) on Equity Investments
-----6.6630.71
Stock-Based Compensation
-2.694.98---
Provision & Write-off of Bad Debts
0.03-0.04-0.040.250.050.13
Other Operating Activities
-8.6813.34-5.119.763.22-7.36
Change in Accounts Receivable
-29.99-41.58-18.06-12.9937.37-57.55
Change in Inventory
-26.92-300.0333.23-69.621.523.69
Change in Accounts Payable
-42.9525.9327.3315.73-5.65-11.07
Change in Unearned Revenue
43.1791.6237.6-0.3428-11.87
Change in Other Net Operating Assets
-29.73-322.64-83.0217.959.6519.41
Operating Cash Flow
114.2-294.39208.23168.8240.77103.71
Operating Cash Flow Growth
--23.36%-29.89%132.16%-33.73%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-157.83-27.67-36.09-80.15-29.75-21.72
Sale of Property, Plant & Equipment
7.086.843.420.911.998.12
Investment in Securities
-72.06-37.52-159.9448.64-30-13.49
Other Investing Activities
8.93-7.04-6.85-9.47-8.11-6.48
Investing Cash Flow
-213.89-65.39-199.46-40.08-65.87-33.57

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-----40
Long-Term Debt Issued
-40021.9250--
Total Debt Issued
25040021.9250-40
Short-Term Debt Repaid
-----60-
Long-Term Debt Repaid
--32.6-80.55-53.47-43.69-38.08
Total Debt Repaid
-71.24-32.6-80.55-53.47-103.69-38.08
Net Debt Issued (Repaid)
178.77367.4-58.62-3.47-103.691.92
Issuance of Common Stock
-138.87221.44---
Common Dividends Paid
-97.24-97.24-64.35-60.06-42.9-53.63
Financing Cash Flow
81.53409.0398.47-63.53-146.59-51.7

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
11.29-4.323.94-1.930.45-0.1
Net Cash Flow
-6.8744.93111.1863.2628.7618.33

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-43.63-322.05172.1488.64211.0281.99
Free Cash Flow Growth
--94.20%-57.99%157.37%15.73%
Free Cash Flow Margin
-4.77%-27.66%20.76%12.99%43.30%13.57%
Free Cash Flow Per Share
-1.62-12.407.464.129.803.81
Levered Free Cash Flow
69.577.43130.71127.5984.4246.88
Unlevered Free Cash Flow
74.9511.74132.36129.3386.5449.19

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
6.756.752.852.643.383.69
Cash Income Tax Paid
37.2637.2648.7237.3330.1828.44
Change in Working Capital
-86.41-546.71-2.92-49.2770.89-57.38